Nova Vascular LLC dba NOVARX vs Stryker Sustainability Solutions: FDA Enforcement Comparison

Stryker Sustainability Solutions has been the subject of 27 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Nova Vascular LLC dba NOVARX.

Nova Vascular LLC dba NOVARX: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.

Stryker Sustainability Solutions: 0 warning letters, 27 recalls, 0 approval records, 0 Form 483s.

Side by side

Nova Vascular LLC dba NOVARX — Warning letters1

Stryker Sustainability Solutions — Warning letters0

Nova Vascular LLC dba NOVARX — Recalls0

Stryker Sustainability Solutions — Recalls27

Nova Vascular LLC dba NOVARX — Approval records0

Stryker Sustainability Solutions — Approval records0

Nova Vascular LLC dba NOVARX — Form 483s0

Stryker Sustainability Solutions — Form 483s0

Timeline

Nova Vascular LLC dba NOVARX

Most recent FDA action: June 8, 2026

Full history →

Stryker Sustainability Solutions

Most recent FDA action: May 20, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Nova Vascular LLC dba NOVARX vs Stryker Sustainability Solutions: FDA Enforcement Comparison." Argus HQ, accessed July 13, 2026. https://argushq.ai/compare/nova-vascular-llc-dba-novarx-vs-stryker-sustainability-solutions

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗